Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma

Chihiro Dohi, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Nozomu Wada, Hideaki Kunugasa, Yasuto Takeuchi, Kenji Kuwaki, Hideki Ohnishi, Fusao Ikeda, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Hiroyuki Okada

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aim: Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after curative treatments. The aim of this study is to elucidate the risk factors for recurrence of HCC after radiofrequency ablation (RFA), focusing on the carcinogenic potential of the liver assessed by α-fetoprotein (AFP). Methods: We enrolled 357 consecutive patients who underwent complete ablation by RFA for primary HCC (≤3 cm, ≤3 tumors) and analyzed the correlation between 17 critical parameters, including AFP and HCC recurrence. Results: Recurrence was observed in 236 patients during a mean observation period of 54.3 months. Multivariate analysis revealed that multiple tumors (risk ratio [RR] = 1.70, 95% confidence interval [CI] = 1.27–2.26, P < 0.001), high AFP (>10 ng/mL, RR = 1.45, 95% CI = 1.09–1.94, P < 0.001) and high des-γ-carboxyprothrombin (>40 mAU/mL, RR = 1.52, 95% CI = 1.13–2.02, P < 0.005) were significantly correlated with recurrence. AFP was selected as a significant factor even when the cut-off level was set lower (≤5 ng/mL). The risk of recurrence increased linearly according to the increase of the lowest AFP level after RFA and the adjusted ratios relative to AFP less than 5 ng/mL were 1.56, 2.14, 2.57 and 3.13 in AFP 5–10 ng/mL, 10–20 ng/mL, 20–50 ng/mL and over 50 ng/mL, respectively. In addition, the recurrence rate was predicted by the AFP level after RFA, regardless of the level before the treatment. Conclusion: AFP less than 5 ng/mL after curative RFA was an important predictor of a better prognosis and was considered to indicate the low carcinogenic potential of the non-cancerous liver.

Original languageEnglish
Pages (from-to)916-923
Number of pages8
JournalHepatology Research
Volume46
Issue number9
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Fetal Proteins
alpha-Fetoproteins
Hepatocellular Carcinoma
Recurrence
Odds Ratio
Confidence Intervals
Liver
Neoplasms
Multivariate Analysis
Observation

Keywords

  • alpha-fetoprotein
  • hepatocellular carcinoma recurrence
  • radiofrequency ablation

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma. / Dohi, Chihiro; Nouso, Kazuhiro; Miyahara, Koji; Morimoto, Yuki; Wada, Nozomu; Kunugasa, Hideaki; Takeuchi, Yasuto; Kuwaki, Kenji; Ohnishi, Hideki; Ikeda, Fusao; Nakamura, Shinichiro; Shiraha, Hidenori; Takaki, Akinobu; Okada, Hiroyuki.

In: Hepatology Research, Vol. 46, No. 9, 01.08.2016, p. 916-923.

Research output: Contribution to journalArticle

Dohi, Chihiro ; Nouso, Kazuhiro ; Miyahara, Koji ; Morimoto, Yuki ; Wada, Nozomu ; Kunugasa, Hideaki ; Takeuchi, Yasuto ; Kuwaki, Kenji ; Ohnishi, Hideki ; Ikeda, Fusao ; Nakamura, Shinichiro ; Shiraha, Hidenori ; Takaki, Akinobu ; Okada, Hiroyuki. / Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma. In: Hepatology Research. 2016 ; Vol. 46, No. 9. pp. 916-923.
@article{f01aed974fc1436889d8981b027603cf,
title = "Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma",
abstract = "Aim: Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after curative treatments. The aim of this study is to elucidate the risk factors for recurrence of HCC after radiofrequency ablation (RFA), focusing on the carcinogenic potential of the liver assessed by α-fetoprotein (AFP). Methods: We enrolled 357 consecutive patients who underwent complete ablation by RFA for primary HCC (≤3 cm, ≤3 tumors) and analyzed the correlation between 17 critical parameters, including AFP and HCC recurrence. Results: Recurrence was observed in 236 patients during a mean observation period of 54.3 months. Multivariate analysis revealed that multiple tumors (risk ratio [RR] = 1.70, 95{\%} confidence interval [CI] = 1.27–2.26, P < 0.001), high AFP (>10 ng/mL, RR = 1.45, 95{\%} CI = 1.09–1.94, P < 0.001) and high des-γ-carboxyprothrombin (>40 mAU/mL, RR = 1.52, 95{\%} CI = 1.13–2.02, P < 0.005) were significantly correlated with recurrence. AFP was selected as a significant factor even when the cut-off level was set lower (≤5 ng/mL). The risk of recurrence increased linearly according to the increase of the lowest AFP level after RFA and the adjusted ratios relative to AFP less than 5 ng/mL were 1.56, 2.14, 2.57 and 3.13 in AFP 5–10 ng/mL, 10–20 ng/mL, 20–50 ng/mL and over 50 ng/mL, respectively. In addition, the recurrence rate was predicted by the AFP level after RFA, regardless of the level before the treatment. Conclusion: AFP less than 5 ng/mL after curative RFA was an important predictor of a better prognosis and was considered to indicate the low carcinogenic potential of the non-cancerous liver.",
keywords = "alpha-fetoprotein, hepatocellular carcinoma recurrence, radiofrequency ablation",
author = "Chihiro Dohi and Kazuhiro Nouso and Koji Miyahara and Yuki Morimoto and Nozomu Wada and Hideaki Kunugasa and Yasuto Takeuchi and Kenji Kuwaki and Hideki Ohnishi and Fusao Ikeda and Shinichiro Nakamura and Hidenori Shiraha and Akinobu Takaki and Hiroyuki Okada",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/hepr.12636",
language = "English",
volume = "46",
pages = "916--923",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma

AU - Dohi, Chihiro

AU - Nouso, Kazuhiro

AU - Miyahara, Koji

AU - Morimoto, Yuki

AU - Wada, Nozomu

AU - Kunugasa, Hideaki

AU - Takeuchi, Yasuto

AU - Kuwaki, Kenji

AU - Ohnishi, Hideki

AU - Ikeda, Fusao

AU - Nakamura, Shinichiro

AU - Shiraha, Hidenori

AU - Takaki, Akinobu

AU - Okada, Hiroyuki

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Aim: Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after curative treatments. The aim of this study is to elucidate the risk factors for recurrence of HCC after radiofrequency ablation (RFA), focusing on the carcinogenic potential of the liver assessed by α-fetoprotein (AFP). Methods: We enrolled 357 consecutive patients who underwent complete ablation by RFA for primary HCC (≤3 cm, ≤3 tumors) and analyzed the correlation between 17 critical parameters, including AFP and HCC recurrence. Results: Recurrence was observed in 236 patients during a mean observation period of 54.3 months. Multivariate analysis revealed that multiple tumors (risk ratio [RR] = 1.70, 95% confidence interval [CI] = 1.27–2.26, P < 0.001), high AFP (>10 ng/mL, RR = 1.45, 95% CI = 1.09–1.94, P < 0.001) and high des-γ-carboxyprothrombin (>40 mAU/mL, RR = 1.52, 95% CI = 1.13–2.02, P < 0.005) were significantly correlated with recurrence. AFP was selected as a significant factor even when the cut-off level was set lower (≤5 ng/mL). The risk of recurrence increased linearly according to the increase of the lowest AFP level after RFA and the adjusted ratios relative to AFP less than 5 ng/mL were 1.56, 2.14, 2.57 and 3.13 in AFP 5–10 ng/mL, 10–20 ng/mL, 20–50 ng/mL and over 50 ng/mL, respectively. In addition, the recurrence rate was predicted by the AFP level after RFA, regardless of the level before the treatment. Conclusion: AFP less than 5 ng/mL after curative RFA was an important predictor of a better prognosis and was considered to indicate the low carcinogenic potential of the non-cancerous liver.

AB - Aim: Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after curative treatments. The aim of this study is to elucidate the risk factors for recurrence of HCC after radiofrequency ablation (RFA), focusing on the carcinogenic potential of the liver assessed by α-fetoprotein (AFP). Methods: We enrolled 357 consecutive patients who underwent complete ablation by RFA for primary HCC (≤3 cm, ≤3 tumors) and analyzed the correlation between 17 critical parameters, including AFP and HCC recurrence. Results: Recurrence was observed in 236 patients during a mean observation period of 54.3 months. Multivariate analysis revealed that multiple tumors (risk ratio [RR] = 1.70, 95% confidence interval [CI] = 1.27–2.26, P < 0.001), high AFP (>10 ng/mL, RR = 1.45, 95% CI = 1.09–1.94, P < 0.001) and high des-γ-carboxyprothrombin (>40 mAU/mL, RR = 1.52, 95% CI = 1.13–2.02, P < 0.005) were significantly correlated with recurrence. AFP was selected as a significant factor even when the cut-off level was set lower (≤5 ng/mL). The risk of recurrence increased linearly according to the increase of the lowest AFP level after RFA and the adjusted ratios relative to AFP less than 5 ng/mL were 1.56, 2.14, 2.57 and 3.13 in AFP 5–10 ng/mL, 10–20 ng/mL, 20–50 ng/mL and over 50 ng/mL, respectively. In addition, the recurrence rate was predicted by the AFP level after RFA, regardless of the level before the treatment. Conclusion: AFP less than 5 ng/mL after curative RFA was an important predictor of a better prognosis and was considered to indicate the low carcinogenic potential of the non-cancerous liver.

KW - alpha-fetoprotein

KW - hepatocellular carcinoma recurrence

KW - radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=84982844611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982844611&partnerID=8YFLogxK

U2 - 10.1111/hepr.12636

DO - 10.1111/hepr.12636

M3 - Article

VL - 46

SP - 916

EP - 923

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 9

ER -